Stories about Over-the-counter drug

Subscribe to Over-the-counter drug

13.10.2020 – 13:44

Stada Arzneimittel
Enyzmatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS countries

Press Release Enyzmatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS countries - Enzymatica has licensed to STADA exclusive rights to market and sell the common cold spray ViruProtect® (ColdZyme®) Coldspray in ...
One document
more
14.09.2020 – 11:36

Stada Arzneimittel

Press release - Romaniszyn leads STADA Poland's growth strategy
One document
more
06.05.2020 – 08:15

Stada Arzneimittel
Bausch + Lomb licenses exclusive rights from STADA and Xbrane to a biosimilar candidate for Lucentis (ranibizumab) in the United States and Canada

BRIDGEWATER, NJ., BAD VILBEL, Germany, and SOLNA, Stockholm, May 06, 2020 – Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC), has entered into an exclusive licensing agreement with STADA ...
One document
more
12.03.2020 – 09:13

Stada Arzneimittel
Press release: STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments

STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments - STADA reported 12% growth in Group sales to EUR 2.61 billion, with a 24% rise in adjusted EBITDA to EUR 625.5 million in its 2019 ...
One document
more
12.03.2020 – 08:12

Stada Arzneimittel
Press release: STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments

STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments - STADA reported 12% growth in Group sales to EUR 2.61 billion, with a 24% rise in adjusted EBITDA to EUR 625.5 million in its 2019 ...
One document
more
04.03.2020 – 08:59

Stada Arzneimittel
Press release: STADA takes clear lead in Russian consumer healthcare sector

Press release STADA takes clear lead in Russian consumer healthcare sector - STADA has today closed a US$660 million transaction of a Russian brand portfolio from Takeda. STADA has reinforced its position as the leading foreign investor in the Russian pharmaceutical industry. - The acquisition of around ...
One document
more
07.02.2020 – 10:34

Stada Arzneimittel

2
STADA to acquire established OTC and food supplement portfolio in the Philippines
One document
more
02.12.2019 – 09:11

Stada Arzneimittel

STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma's Pharmaceutical Prescription and Consumer Health Business
One document
more
05.11.2019 – 08:03

Stada Arzneimittel
Press release: STADA invests $660 Million USD in Takeda's OTC portfolio in Russia/CIS to become a major player in these branded markets

Press release STADA invests $660 Million USD in Takeda's OTC portfolio in Russia/CIS to become a major player in these branded markets - STADA to acquire a portfolio of approximately 20 selected OTC and prescription pharmaceutical products in Russia, ...
One document
more
14.08.2019 – 07:33

Stada Arzneimittel
Press Release - STADA Delivers Strong First-Half 2019 Results

Press Release STADA Delivers Strong First-Half 2019 Results With reported sales growth of 11 percent in the first-half of 2019, STADA is performing well above the industry average. - 11 percent sales growth and a significant 13 percent increase in adjusted EBITDA - growth driven by both the brands/OTC segment and the generics business - Portfolio expansion ...
One document
more

1